Clorox stock just jumped 6.5% in a single session, yet the real story is not a sudden growth surge. It is a margin and cash strain that investors are choosing to look past for now. The company is earning a trailing net margin of 8.7% compared with 11.4% a year earlier, while still carrying a dividend that is not well covered by free cash flow and debt that leans heavily on operating cash.

The headline is simple: the market cheered the print. The earnings still point to a profit quality and balance sheet reckoning that has not gone away.

Is Clorox at 21.6x P/E with an 8.7% margin and a 4.74% dividend a genuine mispricing, or a balance sheet warning sign in disguise? See how the cash flows line up against price in our valuation analysis…